Forecast & Rating3 analysts currently cover Inhibrx Biosciences, of which 2 give a positive rating. The average price target is $277.50, about 197.0% upside from the current price of $93.42. Coverage is limited, so the data is for reference only. Data as of Aug 14, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$277.50197.05%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met53.5%
Stock price$93.42
Avg. target$277.5
High target$325
Low target$230
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.